These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 34741433)

  • 1. Diagnostic performance of SHOX2 promoter methylation as biomarker for lung cancer identification: A meta-analysis update.
    Zhou X; Lu X; Wu H; Liu J; Huang H
    Thorac Cancer; 2021 Dec; 12(24):3327-3332. PubMed ID: 34741433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. APC gene promoter methylation as a potential biomarker for lung cancer diagnosis: A meta-analysis.
    Liu F; Lu X; Zhou X; Huang H
    Thorac Cancer; 2021 Nov; 12(21):2907-2913. PubMed ID: 34545707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnostic Efficacy of SHOX2 Gene Hypermethylation for Lung Cancer: A Meta-Analysis].
    Liu Q; Wang S; Pei G; Yang Y; Huang Y
    Zhongguo Fei Ai Za Zhi; 2021 Jul; 24(7):490-496. PubMed ID: 34275516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MGMT gene promoter methylation in humoral tissue as biomarker for lung cancer diagnosis: An update meta-analysis.
    Chen B; Ying X; Bao L
    Thorac Cancer; 2021 Dec; 12(23):3194-3200. PubMed ID: 34651448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-21 was a promising biomarker for lung carcinoma diagnosis: An update meta-analysis.
    Wang H; Xu J; Ding L
    Thorac Cancer; 2022 Feb; 13(3):316-321. PubMed ID: 34837469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic value of SHOX2 DNA methylation in lung cancer: a meta-analysis.
    Zhao QT; Guo T; Wang HE; Zhang XP; Zhang H; Wang ZK; Yuan Z; Duan GC
    Onco Targets Ther; 2015; 8():3433-9. PubMed ID: 26640383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Novel Diagnosis Method Based on Methylation Analysis of SHOX2 and Serum Biomarker for Early Stage Lung Cancer.
    Huang W; Huang H; Zhang S; Wang X; Ouyang J; Lin Z; Chen P
    Cancer Control; 2020; 27(1):1073274820969703. PubMed ID: 33167712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P16
    Tuo L; Sha S; Huayu Z; Du K
    Thorac Cancer; 2018 Aug; 9(8):1032-1040. PubMed ID: 29927090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA methylation analysis in plasma for early diagnosis in lung adenocarcinoma.
    Jin Y; Lu R; Liu F; Jiang G; Wang R; Zheng M
    Medicine (Baltimore); 2024 Jul; 103(28):e38867. PubMed ID: 38996143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promoter hypermethylation of
    Branchi V; Schaefer P; Semaan A; Kania A; Lingohr P; Kalff JC; Schäfer N; Kristiansen G; Dietrich D; Matthaei H
    Clin Epigenetics; 2016; 8():133. PubMed ID: 27999621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of the SHOX2/PTGER4 DNA Methylation Marker Panel for Plasma-Based Discrimination between Patients with Malignant and Nonmalignant Lung Disease.
    Weiss G; Schlegel A; Kottwitz D; König T; Tetzner R
    J Thorac Oncol; 2017 Jan; 12(1):77-84. PubMed ID: 27544059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-375 Combined with SHOX2 Methylation has Higher Diagnostic Efficacy for Non-Small-Cell Lung Cancer.
    Zeng S; Lin C; Huang Y
    Mol Biotechnol; 2023 Jul; 65(7):1187-1197. PubMed ID: 36462101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SHOX2 DNA methylation is a biomarker for the diagnosis of lung cancer in plasma.
    Kneip C; Schmidt B; Seegebarth A; Weickmann S; Fleischhacker M; Liebenberg V; Field JK; Dietrich D
    J Thorac Oncol; 2011 Oct; 6(10):1632-8. PubMed ID: 21694641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic performance of the nerve root sedimentation sign in lumbar spinal stenosis: a systematic review and meta-analysis.
    Wang G; Peng Z; Li J; Song Z; Wang P
    Neuroradiology; 2019 Oct; 61(10):1111-1121. PubMed ID: 31363807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation Between RASSF1A Gene Promoter Hypermethylation in Serum or Sputum and Non-Small Cell Lung Cancer (NSCLC): A Meta-Analysis.
    Zhang Z; Yan S; Cui H; Chen H; Liu J
    Med Sci Monit; 2019 Jul; 25():5518-5524. PubMed ID: 31342946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic performance of RASSF1A and SHOX2 methylation combined with EGFR mutations for differentiation between small pulmonary nodules.
    Ji XY; Li H; Chen HH; Lin J
    J Cancer Res Clin Oncol; 2023 Sep; 149(11):8557-8571. PubMed ID: 37097393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-analysis of the accuracy for RASSF1A methylation in bronchial aspirates for the diagnosis of lung cancer.
    Chen XP; He SX; Chen MY; Chen FB; Wu P; Shi P; Zhao SC; Zhao LY; Xiong XM; Zeng J
    PLoS One; 2024; 19(7):e0299447. PubMed ID: 39052646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Signaling pathways and clinical application of RASSF1A and SHOX2 in lung cancer.
    Li N; Zeng Y; Huang J
    J Cancer Res Clin Oncol; 2020 Jun; 146(6):1379-1393. PubMed ID: 32266538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic performance of dynamic contrast-enhanced magnetic resonance imaging for breast cancer detection: An update meta-analysis.
    Dong H; Kang L; Cheng S; Zhang R
    Thorac Cancer; 2021 Dec; 12(23):3201-3207. PubMed ID: 34668649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of SHOX2 methylation test in peripheral blood samples used for the differential diagnosis of lung cancer and other lung disorders.
    Konecny M; Markus J; Waczulikova I; Dolesova L; Kozlova R; Repiska V; Novosadova H; Majer I
    Neoplasma; 2016; 63(2):246-53. PubMed ID: 26774146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.